Rheumatology Topics

Screening for JC Polyomavirus Not Yet Useful in Rheumatic Patients Treated with Rituximab

By Wayne Kuznar

Routine screening for replicating JC polyomavirus (JCPyV) or serum antibodies does not seem to be warranted in rheumatic patients treated with rituximab (Rituxan).